Posttransplant Malignancy.
Document Type
Article
Publication Date
2-1-2019
Institution/Department
Nephrology & Transplantation
Journal Title
The Surgical clinics of North America
MeSH Headings
Humans, Immunosuppression, Neoplasms, Organ Transplantation, Risk Factors
Abstract
Posttransplant malignancy is a leading cause of death after solid organ transplantation (SOT). Recipients of SOT are at significantly higher risk of multiple cancers compared with the general population, most notably nonmelanoma skin cancer and posttransplant lymphoproliferative disorders. Risk factors for posttransplant malignancy include history of malignancy, immunosuppression, oncogenic viral infections, sun exposure, and disease-specific associations. Early detection and treatment of malignancies can improve survival.
ISSN
1558-3171
First Page
49
Last Page
64
Recommended Citation
Rossi, Ana P and Klein, Christina L, "Posttransplant Malignancy." (2019). MaineHealth Maine Medical Center. 1365.
https://knowledgeconnection.mainehealth.org/mmc/1365